Kinase Multiplex Kits Search Results


99
Dojindo Labs assays cck8 dojindo
Assays Cck8 Dojindo, supplied by Dojindo Labs, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/assays cck8 dojindo/product/Dojindo Labs
Average 99 stars, based on 1 article reviews
assays cck8 dojindo - by Bioz Stars, 2026-05
99/100 stars
  Buy from Supplier

97
New England Biolabs england biolabs m0204 t4 polynucleotide kinase
England Biolabs M0204 T4 Polynucleotide Kinase, supplied by New England Biolabs, used in various techniques. Bioz Stars score: 97/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/england biolabs m0204 t4 polynucleotide kinase/product/New England Biolabs
Average 97 stars, based on 1 article reviews
england biolabs m0204 t4 polynucleotide kinase - by Bioz Stars, 2026-05
97/100 stars
  Buy from Supplier

93
Cell Signaling Technology Inc pathscan multiplex western cocktail i kit
Pathscan Multiplex Western Cocktail I Kit, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/pathscan multiplex western cocktail i kit/product/Cell Signaling Technology Inc
Average 93 stars, based on 1 article reviews
pathscan multiplex western cocktail i kit - by Bioz Stars, 2026-05
93/100 stars
  Buy from Supplier

93
Cell Signaling Technology Inc phospho p70 s6 kinase thr389
KEY RESOURCES TABLE
Phospho P70 S6 Kinase Thr389, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/phospho p70 s6 kinase thr389/product/Cell Signaling Technology Inc
Average 93 stars, based on 1 article reviews
phospho p70 s6 kinase thr389 - by Bioz Stars, 2026-05
93/100 stars
  Buy from Supplier

99
Thermo Fisher assays milliplex map total phospho erk cell signaling multiplex assay milliport 48 619mag piercetm bca protein assay kit thermofisher scientific cat
KEY RESOURCES TABLE
Assays Milliplex Map Total Phospho Erk Cell Signaling Multiplex Assay Milliport 48 619mag Piercetm Bca Protein Assay Kit Thermofisher Scientific Cat, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/assays milliplex map total phospho erk cell signaling multiplex assay milliport 48 619mag piercetm bca protein assay kit thermofisher scientific cat/product/Thermo Fisher
Average 99 stars, based on 1 article reviews
assays milliplex map total phospho erk cell signaling multiplex assay milliport 48 619mag piercetm bca protein assay kit thermofisher scientific cat - by Bioz Stars, 2026-05
99/100 stars
  Buy from Supplier

90
Meso Scale Diagnostics LLC custom multiplexed elisa kit kidney injury panel 2 (kip-2)
KEY RESOURCES TABLE
Custom Multiplexed Elisa Kit Kidney Injury Panel 2 (Kip 2), supplied by Meso Scale Diagnostics LLC, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/custom multiplexed elisa kit kidney injury panel 2 (kip-2)/product/Meso Scale Diagnostics LLC
Average 90 stars, based on 1 article reviews
custom multiplexed elisa kit kidney injury panel 2 (kip-2) - by Bioz Stars, 2026-05
90/100 stars
  Buy from Supplier

96
Santa Cruz Biotechnology erk 1 k 23
KEY RESOURCES TABLE
Erk 1 K 23, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/erk 1 k 23/product/Santa Cruz Biotechnology
Average 96 stars, based on 1 article reviews
erk 1 k 23 - by Bioz Stars, 2026-05
96/100 stars
  Buy from Supplier

90
Revvity alpha surefire ultra multiplex p erk 1 2 total erk assay
Effect of dynasore and sucrose on HCA 3 and GPR84 cAMP inhibitory and <t>ERK</t> signaling. a Scheme summarizing all inhibitors and their targets used in the present study. b, c CHO-K1 cells were transiently transfected with HCA 3 or GPR84. b 80 μM dynasore reduced cAMP inhibitory signaling of HCA 3 upon 3HO and 3HDec and of GPR84 upon C10 but not 3HDec stimulation. Sucrose (0.4 M) significantly inhibited only the 3HDec-induced HCA 3 -mediated reduction of intracellular cAMP levels. cAMP level of HCA 3 - or GPR84-transfected cells in absence of agonist is set to 100%, respectively. c The agonist-induced phosphorylation of ERK1/2 was measured in absence and presence of dynasore or sucrose. All agonists induced an increase in <t>pERK/total</t> <t>ERK</t> levels upon stimulation of HCA 3 and GPR84, respectively. Dynasore blocked the signal of 100 μM 3HO and 100 μM 3HDec completely and sucrose partially in HCA 3 –transfected cells. Dynasore did not fully block the signal of 100 μM C10 and 100 μM 3HDec in GPR84-transfected cells. The residual ERK signals of GPR84 in presence of 3HDec and dynasore or sucrose did not differ. <t>pERK/total</t> <t>ERK</t> of HCA 3 - or GPR84-transfected cells in absence of agonist is set 1. b, c Data is given as mean ± SEM of at least three independent experiments each carried out in triplicates. * P ≤ 0.05; ** P ≤ 0.01
Alpha Surefire Ultra Multiplex P Erk 1 2 Total Erk Assay, supplied by Revvity, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/alpha surefire ultra multiplex p erk 1 2 total erk assay/product/Revvity
Average 90 stars, based on 1 article reviews
alpha surefire ultra multiplex p erk 1 2 total erk assay - by Bioz Stars, 2026-05
90/100 stars
  Buy from Supplier

95
Cell Signaling Technology Inc assays milliplex map total phospho erk cell signaling multiplex assay milliport 48 619mag piercetm bca protein assay kit thermofisher scientific cat
Effect of dynasore and sucrose on HCA 3 and GPR84 cAMP inhibitory and <t>ERK</t> signaling. a Scheme summarizing all inhibitors and their targets used in the present study. b, c CHO-K1 cells were transiently transfected with HCA 3 or GPR84. b 80 μM dynasore reduced cAMP inhibitory signaling of HCA 3 upon 3HO and 3HDec and of GPR84 upon C10 but not 3HDec stimulation. Sucrose (0.4 M) significantly inhibited only the 3HDec-induced HCA 3 -mediated reduction of intracellular cAMP levels. cAMP level of HCA 3 - or GPR84-transfected cells in absence of agonist is set to 100%, respectively. c The agonist-induced phosphorylation of ERK1/2 was measured in absence and presence of dynasore or sucrose. All agonists induced an increase in <t>pERK/total</t> <t>ERK</t> levels upon stimulation of HCA 3 and GPR84, respectively. Dynasore blocked the signal of 100 μM 3HO and 100 μM 3HDec completely and sucrose partially in HCA 3 –transfected cells. Dynasore did not fully block the signal of 100 μM C10 and 100 μM 3HDec in GPR84-transfected cells. The residual ERK signals of GPR84 in presence of 3HDec and dynasore or sucrose did not differ. <t>pERK/total</t> <t>ERK</t> of HCA 3 - or GPR84-transfected cells in absence of agonist is set 1. b, c Data is given as mean ± SEM of at least three independent experiments each carried out in triplicates. * P ≤ 0.05; ** P ≤ 0.01
Assays Milliplex Map Total Phospho Erk Cell Signaling Multiplex Assay Milliport 48 619mag Piercetm Bca Protein Assay Kit Thermofisher Scientific Cat, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/assays milliplex map total phospho erk cell signaling multiplex assay milliport 48 619mag piercetm bca protein assay kit thermofisher scientific cat/product/Cell Signaling Technology Inc
Average 95 stars, based on 1 article reviews
assays milliplex map total phospho erk cell signaling multiplex assay milliport 48 619mag piercetm bca protein assay kit thermofisher scientific cat - by Bioz Stars, 2026-05
95/100 stars
  Buy from Supplier

96
R&D Systems proteome profiler human phospho kinase array kit
QN-302-mediated increase of p53 levels inhibits DDLPS cell growth. ( A ) Representative western immunoblotting showing the abundance of the indicated proteins in DDLPS cells untreated or exposed for 24 h to 0.4 and 0.8 μM QN-302. ( B ) Dose-response curves of DD-1 and DD-2 cells exposed for 48 and 72 h to increasing concentrations (from 0.025 to 0.8 μM) of QN-302. Data are reported as the percentage inhibition of cell growth with respect to untreated cells as a function of the Log 10 compound concentrations and represent mean values ± SD from at least three independent experiments. ( C ) Time-dependent assessment of cell growth in DDLPS cells untreated or exposed to QN-302 (IC 50 at 48 h). Data are reported as the number of growing cells over time and represent mean values ± SD ( n = 5). *** P < .001 (two-tailed Student’s t -test; n = 5). ( D ) Representative western immunoblotting showing the abundance of MDM2 and p53 proteins at 24, 48, and 72 h in untreated (−) and QN-302 (IC 50 at 48 h)-treated (+) DDLPS cells. ( E ) Representative western immunoblotting showing the abundance of MDM2 and p53 proteins in DDLPS cells, untreated (−) and after a 1-h exposure to QN-302 (0.8 μM), followed by the recovery for 24, 48, and 72 h in drug-free medium. The drawing on the top depicts the experimental scheme. ( F ) Representative western immunoblotting showing the abundance of MDM2 and p53 proteins in non-transfected (UNT), siCTR-, and sip53-transfected DD-1 and DD-2 cells either untreated (−) and after a 48-h exposure (+) to QN-302 (IC 50 at 48 h). In all western immunoblotting data, cropped images of selected proteins are shown. VCL was used to ensure equal protein loading. ( G ) Representative blot from the Human Phospho-Kinase <t>Proteome</t> Profiler Array showing the phosphorylation status of p53 at <t>serine</t> <t>S15,</t> S46, and S392 in DDLPS untreated (−) and after a 48-h exposure to an equitoxic amount (IC 50 at 48 h) of QN-302.
Proteome Profiler Human Phospho Kinase Array Kit, supplied by R&D Systems, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/proteome profiler human phospho kinase array kit/product/R&D Systems
Average 96 stars, based on 1 article reviews
proteome profiler human phospho kinase array kit - by Bioz Stars, 2026-05
96/100 stars
  Buy from Supplier

94
Cell Signaling Technology Inc phosphoplus p70 s6 kinase
QN-302-mediated increase of p53 levels inhibits DDLPS cell growth. ( A ) Representative western immunoblotting showing the abundance of the indicated proteins in DDLPS cells untreated or exposed for 24 h to 0.4 and 0.8 μM QN-302. ( B ) Dose-response curves of DD-1 and DD-2 cells exposed for 48 and 72 h to increasing concentrations (from 0.025 to 0.8 μM) of QN-302. Data are reported as the percentage inhibition of cell growth with respect to untreated cells as a function of the Log 10 compound concentrations and represent mean values ± SD from at least three independent experiments. ( C ) Time-dependent assessment of cell growth in DDLPS cells untreated or exposed to QN-302 (IC 50 at 48 h). Data are reported as the number of growing cells over time and represent mean values ± SD ( n = 5). *** P < .001 (two-tailed Student’s t -test; n = 5). ( D ) Representative western immunoblotting showing the abundance of MDM2 and p53 proteins at 24, 48, and 72 h in untreated (−) and QN-302 (IC 50 at 48 h)-treated (+) DDLPS cells. ( E ) Representative western immunoblotting showing the abundance of MDM2 and p53 proteins in DDLPS cells, untreated (−) and after a 1-h exposure to QN-302 (0.8 μM), followed by the recovery for 24, 48, and 72 h in drug-free medium. The drawing on the top depicts the experimental scheme. ( F ) Representative western immunoblotting showing the abundance of MDM2 and p53 proteins in non-transfected (UNT), siCTR-, and sip53-transfected DD-1 and DD-2 cells either untreated (−) and after a 48-h exposure (+) to QN-302 (IC 50 at 48 h). In all western immunoblotting data, cropped images of selected proteins are shown. VCL was used to ensure equal protein loading. ( G ) Representative blot from the Human Phospho-Kinase <t>Proteome</t> Profiler Array showing the phosphorylation status of p53 at <t>serine</t> <t>S15,</t> S46, and S392 in DDLPS untreated (−) and after a 48-h exposure to an equitoxic amount (IC 50 at 48 h) of QN-302.
Phosphoplus P70 S6 Kinase, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/phosphoplus p70 s6 kinase/product/Cell Signaling Technology Inc
Average 94 stars, based on 1 article reviews
phosphoplus p70 s6 kinase - by Bioz Stars, 2026-05
94/100 stars
  Buy from Supplier

99
Zymo Research direct zol rna mini prep kit zymo research cat
QN-302-mediated increase of p53 levels inhibits DDLPS cell growth. ( A ) Representative western immunoblotting showing the abundance of the indicated proteins in DDLPS cells untreated or exposed for 24 h to 0.4 and 0.8 μM QN-302. ( B ) Dose-response curves of DD-1 and DD-2 cells exposed for 48 and 72 h to increasing concentrations (from 0.025 to 0.8 μM) of QN-302. Data are reported as the percentage inhibition of cell growth with respect to untreated cells as a function of the Log 10 compound concentrations and represent mean values ± SD from at least three independent experiments. ( C ) Time-dependent assessment of cell growth in DDLPS cells untreated or exposed to QN-302 (IC 50 at 48 h). Data are reported as the number of growing cells over time and represent mean values ± SD ( n = 5). *** P < .001 (two-tailed Student’s t -test; n = 5). ( D ) Representative western immunoblotting showing the abundance of MDM2 and p53 proteins at 24, 48, and 72 h in untreated (−) and QN-302 (IC 50 at 48 h)-treated (+) DDLPS cells. ( E ) Representative western immunoblotting showing the abundance of MDM2 and p53 proteins in DDLPS cells, untreated (−) and after a 1-h exposure to QN-302 (0.8 μM), followed by the recovery for 24, 48, and 72 h in drug-free medium. The drawing on the top depicts the experimental scheme. ( F ) Representative western immunoblotting showing the abundance of MDM2 and p53 proteins in non-transfected (UNT), siCTR-, and sip53-transfected DD-1 and DD-2 cells either untreated (−) and after a 48-h exposure (+) to QN-302 (IC 50 at 48 h). In all western immunoblotting data, cropped images of selected proteins are shown. VCL was used to ensure equal protein loading. ( G ) Representative blot from the Human Phospho-Kinase <t>Proteome</t> Profiler Array showing the phosphorylation status of p53 at <t>serine</t> <t>S15,</t> S46, and S392 in DDLPS untreated (−) and after a 48-h exposure to an equitoxic amount (IC 50 at 48 h) of QN-302.
Direct Zol Rna Mini Prep Kit Zymo Research Cat, supplied by Zymo Research, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/direct zol rna mini prep kit zymo research cat/product/Zymo Research
Average 99 stars, based on 1 article reviews
direct zol rna mini prep kit zymo research cat - by Bioz Stars, 2026-05
99/100 stars
  Buy from Supplier

Image Search Results


KEY RESOURCES TABLE

Journal: Cell metabolism

Article Title: Arginase 2 Suppresses Renal Carcinoma Progression via Biosynthetic Cofactor Pyridoxal Phosphate Depletion and Increased Polyamine Toxicity

doi: 10.1016/j.cmet.2018.04.009

Figure Lengend Snippet: KEY RESOURCES TABLE

Article Snippet: phospho-p70 S6 Kinase (Thr389) , Cell Signaling , #9234.

Techniques: Recombinant, Multiplex sample analysis, Arginase Activity Assay, Colorimetric Assay, Mutagenesis, Software

Effect of dynasore and sucrose on HCA 3 and GPR84 cAMP inhibitory and ERK signaling. a Scheme summarizing all inhibitors and their targets used in the present study. b, c CHO-K1 cells were transiently transfected with HCA 3 or GPR84. b 80 μM dynasore reduced cAMP inhibitory signaling of HCA 3 upon 3HO and 3HDec and of GPR84 upon C10 but not 3HDec stimulation. Sucrose (0.4 M) significantly inhibited only the 3HDec-induced HCA 3 -mediated reduction of intracellular cAMP levels. cAMP level of HCA 3 - or GPR84-transfected cells in absence of agonist is set to 100%, respectively. c The agonist-induced phosphorylation of ERK1/2 was measured in absence and presence of dynasore or sucrose. All agonists induced an increase in pERK/total ERK levels upon stimulation of HCA 3 and GPR84, respectively. Dynasore blocked the signal of 100 μM 3HO and 100 μM 3HDec completely and sucrose partially in HCA 3 –transfected cells. Dynasore did not fully block the signal of 100 μM C10 and 100 μM 3HDec in GPR84-transfected cells. The residual ERK signals of GPR84 in presence of 3HDec and dynasore or sucrose did not differ. pERK/total ERK of HCA 3 - or GPR84-transfected cells in absence of agonist is set 1. b, c Data is given as mean ± SEM of at least three independent experiments each carried out in triplicates. * P ≤ 0.05; ** P ≤ 0.01

Journal: Cell Communication and Signaling : CCS

Article Title: Natural biased signaling of hydroxycarboxylic acid receptor 3 and G protein-coupled receptor 84

doi: 10.1186/s12964-020-0516-2

Figure Lengend Snippet: Effect of dynasore and sucrose on HCA 3 and GPR84 cAMP inhibitory and ERK signaling. a Scheme summarizing all inhibitors and their targets used in the present study. b, c CHO-K1 cells were transiently transfected with HCA 3 or GPR84. b 80 μM dynasore reduced cAMP inhibitory signaling of HCA 3 upon 3HO and 3HDec and of GPR84 upon C10 but not 3HDec stimulation. Sucrose (0.4 M) significantly inhibited only the 3HDec-induced HCA 3 -mediated reduction of intracellular cAMP levels. cAMP level of HCA 3 - or GPR84-transfected cells in absence of agonist is set to 100%, respectively. c The agonist-induced phosphorylation of ERK1/2 was measured in absence and presence of dynasore or sucrose. All agonists induced an increase in pERK/total ERK levels upon stimulation of HCA 3 and GPR84, respectively. Dynasore blocked the signal of 100 μM 3HO and 100 μM 3HDec completely and sucrose partially in HCA 3 –transfected cells. Dynasore did not fully block the signal of 100 μM C10 and 100 μM 3HDec in GPR84-transfected cells. The residual ERK signals of GPR84 in presence of 3HDec and dynasore or sucrose did not differ. pERK/total ERK of HCA 3 - or GPR84-transfected cells in absence of agonist is set 1. b, c Data is given as mean ± SEM of at least three independent experiments each carried out in triplicates. * P ≤ 0.05; ** P ≤ 0.01

Article Snippet: pErk/total Erk content of cell extracts was determined by the Alpha SureFire Ultra Multiplex p-ERK 1/2 + Total ERK assay according to the manufacturer’s protocol (Perkin Elmer LAS).

Techniques: Transfection, Phospho-proteomics, Blocking Assay

Effect of dyn-2 mutants on HCA 3 and GPR84 cell surface expression, cAMP inhibitory signaling and ERK activation. a-c CHO-K1 cells were transiently co-transfected with HCA 3 or GPR84 and dyn-2 wt, dyn-2 K44A or R399A mutants. a In comparison to dyn-2 wt co-transfected cells HCA 3 and GPR84 cell surface expression was significantly reduced when K44A or R399A were co-transfected. b Basal activity of HCA 3 but not GPR84 was diminished in presence of K44A. Agonist-induced (HCA 3 : 6.25 μM 3HO, 25 μM 3HDec; GPR84: 100 μM C10, 25 μM 3HDec) inhibition of forskolin-stimulated cAMP accumulation was reduced in presence of K44A compared to dyn-2 wt whereas R399A did not affect cAMP inhibitory signaling. c Agonist-induced increase of pERK/total ERK level of HCA 3 (25 μM 3HO, 100 μM 3HDec) and GPR84 (25 μM C10, 25 μM 3HDec) was reduced in presence of K44A and R399A compared to dyn-2 wt. a-c Data is given as mean ± SEM of at least three independent experiments each carried out in triplicates. * P ≤ 0.05; ** P ≤ 0.01, *** P ≤ 0.001 ( d ) Images of HEK293-T cells transiently co-expressing HCA 3 -mRuby (red) or GPR84-mRuby and dyn-2-YFP variants (green). In presence of dyn-2 wt, HCA 3 was detected intracellularly and at the plasma membrane where it co-localized with dyn-2 wt. In case of co-expression of HCA 3 with the dyn-2 mutants K44A and R399A, co-localization was detected in perinuclear vesicles as well as certain areas at the plasma membrane. GPR84 was in presence of all dyn-2 variants found mostly at the plasma membrane

Journal: Cell Communication and Signaling : CCS

Article Title: Natural biased signaling of hydroxycarboxylic acid receptor 3 and G protein-coupled receptor 84

doi: 10.1186/s12964-020-0516-2

Figure Lengend Snippet: Effect of dyn-2 mutants on HCA 3 and GPR84 cell surface expression, cAMP inhibitory signaling and ERK activation. a-c CHO-K1 cells were transiently co-transfected with HCA 3 or GPR84 and dyn-2 wt, dyn-2 K44A or R399A mutants. a In comparison to dyn-2 wt co-transfected cells HCA 3 and GPR84 cell surface expression was significantly reduced when K44A or R399A were co-transfected. b Basal activity of HCA 3 but not GPR84 was diminished in presence of K44A. Agonist-induced (HCA 3 : 6.25 μM 3HO, 25 μM 3HDec; GPR84: 100 μM C10, 25 μM 3HDec) inhibition of forskolin-stimulated cAMP accumulation was reduced in presence of K44A compared to dyn-2 wt whereas R399A did not affect cAMP inhibitory signaling. c Agonist-induced increase of pERK/total ERK level of HCA 3 (25 μM 3HO, 100 μM 3HDec) and GPR84 (25 μM C10, 25 μM 3HDec) was reduced in presence of K44A and R399A compared to dyn-2 wt. a-c Data is given as mean ± SEM of at least three independent experiments each carried out in triplicates. * P ≤ 0.05; ** P ≤ 0.01, *** P ≤ 0.001 ( d ) Images of HEK293-T cells transiently co-expressing HCA 3 -mRuby (red) or GPR84-mRuby and dyn-2-YFP variants (green). In presence of dyn-2 wt, HCA 3 was detected intracellularly and at the plasma membrane where it co-localized with dyn-2 wt. In case of co-expression of HCA 3 with the dyn-2 mutants K44A and R399A, co-localization was detected in perinuclear vesicles as well as certain areas at the plasma membrane. GPR84 was in presence of all dyn-2 variants found mostly at the plasma membrane

Article Snippet: pErk/total Erk content of cell extracts was determined by the Alpha SureFire Ultra Multiplex p-ERK 1/2 + Total ERK assay according to the manufacturer’s protocol (Perkin Elmer LAS).

Techniques: Expressing, Activation Assay, Transfection, Comparison, Activity Assay, Inhibition, Clinical Proteomics, Membrane

Role of β-arrestin-2 for HCA 3 and GPR84 signaling and effect of methyl-β-cyclodextrin (MβCD). a, b CHO-K1 cells were transiently transfected with HCA 3 or GPR84. a MβCD inhibited both, the 3HO- and 3HDec-induced reduction of forskolin (fsk)-induced cAMP levels in HCA 3 -transfected cells. For GPR84, only the C10-induced but not the 3HDec-induced decrease in cAMP was inhibited. Barbardin (100 µM) inhibited only the 3HO-induced HCA 3 -mediated reduction of cAMP levels. cAMP levels of HCA 3 - or GPR84-transfected cells in absence of agonist are set 100%, respectively. b 3 mM MβCD did not affect HCA 3 -mediated activation of ERK by 3HO, but caused a decrease of the signal induced by 100 μM 3HDec. Presence of MβCD caused a decrease in C10-induced GPR84-mediated ERK activation and had no effect on the 3HDec-induced ERK activation. The HCA 3 -mediated activation of ERK by 3HO, but not 3HDec, was inhibited in presence of barbardin. Barbardin had no effect on the GPR84-mediated activation of ERK by 3HDec and C10. pERK/total ERK of HCA 3 - or GPR84-transfected cells in absence of agonist is set 1, respectively. c Live-cell images of HEK293-T cells co-expressing HCA 3 -mRuby (red) and β-arrestin-2-YFP (green) were acquired before stimulation and 30 min post-stimulation with 100 μM 3HO or 100 μM 3HDec. d HEK293-T cells stably expressing β-arrestin-2-EA cells transiently transfected with HCA 3 were stimulated with 3HO and 3HDec. Quantification of β-arrestin-2 recruitment using the PathHunter β-arrestin assay (Eurofins DiscoverX) showed recruitment of β-arrestin-2 by HCA 3 following 3HO but not 3HDec stimulation. Luminescence of HCA 3 or empty vector transfected cells in absence of agonist is set 1, respectively. a, b, d Data is given as mean ± SEM of at least three independent experiments each carried out in triplicates. # P ≤ 0.1* P ≤ 0.05; ** P ≤ 0.01

Journal: Cell Communication and Signaling : CCS

Article Title: Natural biased signaling of hydroxycarboxylic acid receptor 3 and G protein-coupled receptor 84

doi: 10.1186/s12964-020-0516-2

Figure Lengend Snippet: Role of β-arrestin-2 for HCA 3 and GPR84 signaling and effect of methyl-β-cyclodextrin (MβCD). a, b CHO-K1 cells were transiently transfected with HCA 3 or GPR84. a MβCD inhibited both, the 3HO- and 3HDec-induced reduction of forskolin (fsk)-induced cAMP levels in HCA 3 -transfected cells. For GPR84, only the C10-induced but not the 3HDec-induced decrease in cAMP was inhibited. Barbardin (100 µM) inhibited only the 3HO-induced HCA 3 -mediated reduction of cAMP levels. cAMP levels of HCA 3 - or GPR84-transfected cells in absence of agonist are set 100%, respectively. b 3 mM MβCD did not affect HCA 3 -mediated activation of ERK by 3HO, but caused a decrease of the signal induced by 100 μM 3HDec. Presence of MβCD caused a decrease in C10-induced GPR84-mediated ERK activation and had no effect on the 3HDec-induced ERK activation. The HCA 3 -mediated activation of ERK by 3HO, but not 3HDec, was inhibited in presence of barbardin. Barbardin had no effect on the GPR84-mediated activation of ERK by 3HDec and C10. pERK/total ERK of HCA 3 - or GPR84-transfected cells in absence of agonist is set 1, respectively. c Live-cell images of HEK293-T cells co-expressing HCA 3 -mRuby (red) and β-arrestin-2-YFP (green) were acquired before stimulation and 30 min post-stimulation with 100 μM 3HO or 100 μM 3HDec. d HEK293-T cells stably expressing β-arrestin-2-EA cells transiently transfected with HCA 3 were stimulated with 3HO and 3HDec. Quantification of β-arrestin-2 recruitment using the PathHunter β-arrestin assay (Eurofins DiscoverX) showed recruitment of β-arrestin-2 by HCA 3 following 3HO but not 3HDec stimulation. Luminescence of HCA 3 or empty vector transfected cells in absence of agonist is set 1, respectively. a, b, d Data is given as mean ± SEM of at least three independent experiments each carried out in triplicates. # P ≤ 0.1* P ≤ 0.05; ** P ≤ 0.01

Article Snippet: pErk/total Erk content of cell extracts was determined by the Alpha SureFire Ultra Multiplex p-ERK 1/2 + Total ERK assay according to the manufacturer’s protocol (Perkin Elmer LAS).

Techniques: Transfection, Activation Assay, Expressing, Stable Transfection, PathHunter β-Arrestin Assay, Plasmid Preparation

Effect of gallein, an inhibitor of Gβγ subunits, on agonist-induced reduction of cAMP levels and ERK activation of HCA 3 and GPR84. CHO-K1 cells were transiently transfected with HCA 3 or GPR84. a The HCA 3 -mediated reduction of forskolin (fsk)-induced cAMP levels induced by both, 3HO and 3HDec, was significantly diminished in presence of 50 μM gallein. The GPR84-induced decrease in cAMP levels in presence of gallein was only reduced in case of activation by C10 but not 3HDec. cAMP level of HCA 3 - or GPR84-transfected cells in absence of agonist is set 100%, respectively. b Gallein inhibited the 3HDec-induced HCA 3 -mediated increase in pERK/total ERK levels completely but the 3HO-induced increase only partially. GPR84-mediated activation of ERK by both, C10 and 3HDec, was equally diminished in presence of gallein. pERK/total ERK of HCA 3 - or GPR84-transfected cells in absence of agonist is set 1, respectively. a, b Data is given as mean ± SEM of at least three independent experiments each carried out in triplicates. * P ≤ 0.05; ** P ≤ 0.01; *** P ≤ 0.001

Journal: Cell Communication and Signaling : CCS

Article Title: Natural biased signaling of hydroxycarboxylic acid receptor 3 and G protein-coupled receptor 84

doi: 10.1186/s12964-020-0516-2

Figure Lengend Snippet: Effect of gallein, an inhibitor of Gβγ subunits, on agonist-induced reduction of cAMP levels and ERK activation of HCA 3 and GPR84. CHO-K1 cells were transiently transfected with HCA 3 or GPR84. a The HCA 3 -mediated reduction of forskolin (fsk)-induced cAMP levels induced by both, 3HO and 3HDec, was significantly diminished in presence of 50 μM gallein. The GPR84-induced decrease in cAMP levels in presence of gallein was only reduced in case of activation by C10 but not 3HDec. cAMP level of HCA 3 - or GPR84-transfected cells in absence of agonist is set 100%, respectively. b Gallein inhibited the 3HDec-induced HCA 3 -mediated increase in pERK/total ERK levels completely but the 3HO-induced increase only partially. GPR84-mediated activation of ERK by both, C10 and 3HDec, was equally diminished in presence of gallein. pERK/total ERK of HCA 3 - or GPR84-transfected cells in absence of agonist is set 1, respectively. a, b Data is given as mean ± SEM of at least three independent experiments each carried out in triplicates. * P ≤ 0.05; ** P ≤ 0.01; *** P ≤ 0.001

Article Snippet: pErk/total Erk content of cell extracts was determined by the Alpha SureFire Ultra Multiplex p-ERK 1/2 + Total ERK assay according to the manufacturer’s protocol (Perkin Elmer LAS).

Techniques: Activation Assay, Transfection

Components involved in HCA 3 and GPR84 signal transduction. a, b Agonist-induced phosphorylation of endogenous ERK1/2 in cellular lysates of HCA 3 or GPR84 transfected CHO-K1 cells in absence and presence of 25 μM ZA (zoledronic acid - inhibitor of ras/rho), 100 μM NSC23766 (inhibitor of rac1) and 25 μM Ly294002 (inhibitor of PI3K) was determined. a ZA, NSC23766 and Ly294002 partially inhibited the HCA 3 -induced ERK activation of both agonists. ZA and Ly 294,002 caused a significant reduction of the GPR84-mediated ERK activation by C10, whereas the ERK activation by 3HDec was only affected by presence of Ly294002. NSC23766 did not inhibit the GPR84-induced activation of ERK by either agonist. b Both, the 3HO- and 3HDec-induced ERK activation of HCA 3 did not persist upon removal of agonist. The GPR84-mediated activation of ERK by 3HDec persisted, whereas the C10-induced activation was almost completely diminished 10 min past agonist removal. a, b pERK/total ERK of HCA 3 - or GPR84-transfected cells in absence of agonist is set 1, respectively. Data is given as mean ± SEM of at least three independent experiments each carried out in triplicates. # P ≤ 0.1; * P ≤ 0.05; ** P ≤ 0.01; *** P ≤ 0.001. c 3HO- and 3HDec-induced cAMP inhibitory signaling of HCA 3 was dependent on Gαi, Gβγ subunits and dyn (internalization). Signaling components involved in HCA 3 -mediated ERK activation by 3HO an 3HDec included Gβγ subunits, PI3K, rac1 and ras/rho. HCA 3 activation by 3HO led to β-arrestin-2 recruitment, which was not the case for 3HDec. ERK signaling of HCA 3 by 3HO involved clathrin and by 3HDec caveolin. GPR84 activation by C10 was dependent on Gαi, Gβγ subunits, dyn (internalization), caveolin, ras/rho and PI3K. In contrast, 3HDec-induced cAMP inhibitory signaling was not dependent on Gβγ subunits, dyn, caveolin or clathrin, thus internalization. ERK activation induced by GPR84 upon 3HDec stimulation persisted upon agonist removal and involved PI3K

Journal: Cell Communication and Signaling : CCS

Article Title: Natural biased signaling of hydroxycarboxylic acid receptor 3 and G protein-coupled receptor 84

doi: 10.1186/s12964-020-0516-2

Figure Lengend Snippet: Components involved in HCA 3 and GPR84 signal transduction. a, b Agonist-induced phosphorylation of endogenous ERK1/2 in cellular lysates of HCA 3 or GPR84 transfected CHO-K1 cells in absence and presence of 25 μM ZA (zoledronic acid - inhibitor of ras/rho), 100 μM NSC23766 (inhibitor of rac1) and 25 μM Ly294002 (inhibitor of PI3K) was determined. a ZA, NSC23766 and Ly294002 partially inhibited the HCA 3 -induced ERK activation of both agonists. ZA and Ly 294,002 caused a significant reduction of the GPR84-mediated ERK activation by C10, whereas the ERK activation by 3HDec was only affected by presence of Ly294002. NSC23766 did not inhibit the GPR84-induced activation of ERK by either agonist. b Both, the 3HO- and 3HDec-induced ERK activation of HCA 3 did not persist upon removal of agonist. The GPR84-mediated activation of ERK by 3HDec persisted, whereas the C10-induced activation was almost completely diminished 10 min past agonist removal. a, b pERK/total ERK of HCA 3 - or GPR84-transfected cells in absence of agonist is set 1, respectively. Data is given as mean ± SEM of at least three independent experiments each carried out in triplicates. # P ≤ 0.1; * P ≤ 0.05; ** P ≤ 0.01; *** P ≤ 0.001. c 3HO- and 3HDec-induced cAMP inhibitory signaling of HCA 3 was dependent on Gαi, Gβγ subunits and dyn (internalization). Signaling components involved in HCA 3 -mediated ERK activation by 3HO an 3HDec included Gβγ subunits, PI3K, rac1 and ras/rho. HCA 3 activation by 3HO led to β-arrestin-2 recruitment, which was not the case for 3HDec. ERK signaling of HCA 3 by 3HO involved clathrin and by 3HDec caveolin. GPR84 activation by C10 was dependent on Gαi, Gβγ subunits, dyn (internalization), caveolin, ras/rho and PI3K. In contrast, 3HDec-induced cAMP inhibitory signaling was not dependent on Gβγ subunits, dyn, caveolin or clathrin, thus internalization. ERK activation induced by GPR84 upon 3HDec stimulation persisted upon agonist removal and involved PI3K

Article Snippet: pErk/total Erk content of cell extracts was determined by the Alpha SureFire Ultra Multiplex p-ERK 1/2 + Total ERK assay according to the manufacturer’s protocol (Perkin Elmer LAS).

Techniques: Transduction, Phospho-proteomics, Transfection, Activation Assay

QN-302-mediated increase of p53 levels inhibits DDLPS cell growth. ( A ) Representative western immunoblotting showing the abundance of the indicated proteins in DDLPS cells untreated or exposed for 24 h to 0.4 and 0.8 μM QN-302. ( B ) Dose-response curves of DD-1 and DD-2 cells exposed for 48 and 72 h to increasing concentrations (from 0.025 to 0.8 μM) of QN-302. Data are reported as the percentage inhibition of cell growth with respect to untreated cells as a function of the Log 10 compound concentrations and represent mean values ± SD from at least three independent experiments. ( C ) Time-dependent assessment of cell growth in DDLPS cells untreated or exposed to QN-302 (IC 50 at 48 h). Data are reported as the number of growing cells over time and represent mean values ± SD ( n = 5). *** P < .001 (two-tailed Student’s t -test; n = 5). ( D ) Representative western immunoblotting showing the abundance of MDM2 and p53 proteins at 24, 48, and 72 h in untreated (−) and QN-302 (IC 50 at 48 h)-treated (+) DDLPS cells. ( E ) Representative western immunoblotting showing the abundance of MDM2 and p53 proteins in DDLPS cells, untreated (−) and after a 1-h exposure to QN-302 (0.8 μM), followed by the recovery for 24, 48, and 72 h in drug-free medium. The drawing on the top depicts the experimental scheme. ( F ) Representative western immunoblotting showing the abundance of MDM2 and p53 proteins in non-transfected (UNT), siCTR-, and sip53-transfected DD-1 and DD-2 cells either untreated (−) and after a 48-h exposure (+) to QN-302 (IC 50 at 48 h). In all western immunoblotting data, cropped images of selected proteins are shown. VCL was used to ensure equal protein loading. ( G ) Representative blot from the Human Phospho-Kinase Proteome Profiler Array showing the phosphorylation status of p53 at serine S15, S46, and S392 in DDLPS untreated (−) and after a 48-h exposure to an equitoxic amount (IC 50 at 48 h) of QN-302.

Journal: Nucleic Acids Research

Article Title: The G-quadruplex experimental drug QN-302 impairs liposarcoma cell growth by inhibiting MDM2 expression and restoring p53 levels

doi: 10.1093/nar/gkaf085

Figure Lengend Snippet: QN-302-mediated increase of p53 levels inhibits DDLPS cell growth. ( A ) Representative western immunoblotting showing the abundance of the indicated proteins in DDLPS cells untreated or exposed for 24 h to 0.4 and 0.8 μM QN-302. ( B ) Dose-response curves of DD-1 and DD-2 cells exposed for 48 and 72 h to increasing concentrations (from 0.025 to 0.8 μM) of QN-302. Data are reported as the percentage inhibition of cell growth with respect to untreated cells as a function of the Log 10 compound concentrations and represent mean values ± SD from at least three independent experiments. ( C ) Time-dependent assessment of cell growth in DDLPS cells untreated or exposed to QN-302 (IC 50 at 48 h). Data are reported as the number of growing cells over time and represent mean values ± SD ( n = 5). *** P < .001 (two-tailed Student’s t -test; n = 5). ( D ) Representative western immunoblotting showing the abundance of MDM2 and p53 proteins at 24, 48, and 72 h in untreated (−) and QN-302 (IC 50 at 48 h)-treated (+) DDLPS cells. ( E ) Representative western immunoblotting showing the abundance of MDM2 and p53 proteins in DDLPS cells, untreated (−) and after a 1-h exposure to QN-302 (0.8 μM), followed by the recovery for 24, 48, and 72 h in drug-free medium. The drawing on the top depicts the experimental scheme. ( F ) Representative western immunoblotting showing the abundance of MDM2 and p53 proteins in non-transfected (UNT), siCTR-, and sip53-transfected DD-1 and DD-2 cells either untreated (−) and after a 48-h exposure (+) to QN-302 (IC 50 at 48 h). In all western immunoblotting data, cropped images of selected proteins are shown. VCL was used to ensure equal protein loading. ( G ) Representative blot from the Human Phospho-Kinase Proteome Profiler Array showing the phosphorylation status of p53 at serine S15, S46, and S392 in DDLPS untreated (−) and after a 48-h exposure to an equitoxic amount (IC 50 at 48 h) of QN-302.

Article Snippet: To evaluate the phosphorylation status of p53 at multiple serine residues (S15, S392, and S46), a multiplex antibody array (Proteome Profiler Human Phospho-Kinase Array Kit, #ARY003C; R&D Systems, Bio-Techne SRL, Milan, Italy) was used, according to the manufacturer’s instructions.

Techniques: Western Blot, Inhibition, Two Tailed Test, Transfection, Phospho-proteomics